Your browser doesn't support javascript.
loading
Quantifying the Cost of Shigella Diarrhea in the Enterics for Global Health (EFGH) Shigella Surveillance Study.
Morozoff, Chloe; Ahmed, Naveed; Chinkhumba, Jobiba; Islam, Md Taufiqul; Jallow, Abdoulie F; Ogwel, Billy; Zegarra Paredes, Loyda Fiorella; Sanogo, Doh; Atlas, Hannah E; Badji, Henry; Bar-Zeev, Naor; Conteh, Bakary; Güimack Fajardo, Mario; Feutz, Erika; Haidara, Fadima C; Karim, Mehrab; Mamby Keita, Adama; Keita, Youssouf; Khanam, Farhana; Kosek, Margaret N; Kotloff, Karen L; Maguire, Rebecca; Mbutuka, Ishmail S; Ndalama, Maureen; Ochieng, John Benjamin; Okello, Collins; Omore, Richard; Perez Garcia, Karin F; Qamar, Farah Naz; Qudrat-E-Khuda, Syed; Qureshi, Sonia; Rajib, Md Nazmul Hasan; Shapiama Lopez, Wagner Valentino; Sultana, Shazia; Witte, Desiree; Yousafzai, Mohammad Tahir; Awuor, Alex O; Cunliffe, Nigel A; Jahangir Hossain, M; Paredes Olortegui, Maribel; Tapia, Milagritos D; Zaman, K; Means, Arianna Rubin.
Affiliation
  • Morozoff C; Department of Global Health, University of Washington, Seattle, Washington, USA.
  • Ahmed N; Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
  • Chinkhumba J; School of Global and Public Health, Department of Health Systems and Policy, Kamuzu University of Health Sciences, Blantyre, Malawi.
  • Islam MT; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research,Bangladesh Dhaka, Bangladesh.
  • Jallow AF; Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Fajara, The Gambia.
  • Ogwel B; Kenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.
  • Zegarra Paredes LF; Asociación Benéfica PRISMA, Iquitos, Peru.
  • Sanogo D; Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.
  • Atlas HE; Department of Global Health, University of Washington, Seattle, Washington, USA.
  • Badji H; Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Fajara, The Gambia.
  • Bar-Zeev N; International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Conteh B; Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Fajara, The Gambia.
  • Güimack Fajardo M; Asociación Benéfica PRISMA, Iquitos, Peru.
  • Feutz E; Department of Global Health, University of Washington, Seattle, Washington, USA.
  • Haidara FC; Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.
  • Karim M; Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Fajara, The Gambia.
  • Mamby Keita A; Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.
  • Keita Y; Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.
  • Khanam F; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research,Bangladesh Dhaka, Bangladesh.
  • Kosek MN; Division of Infectious Diseases and International Health, School of Medicine, University of Virginia, Charlottesville, Virginia, USA.
  • Kotloff KL; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Maguire R; Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Mbutuka IS; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Ndalama M; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Ochieng JB; Malawi Liverpool Wellcome Programme, Blantyre, Malawi.
  • Okello C; Malawi Liverpool Wellcome Programme, Blantyre, Malawi.
  • Omore R; Kenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.
  • Perez Garcia KF; Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.
  • Qamar FN; Kenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.
  • Qudrat-E-Khuda S; Asociación Benéfica PRISMA, Iquitos, Peru.
  • Qureshi S; Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
  • Rajib MNH; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research,Bangladesh Dhaka, Bangladesh.
  • Shapiama Lopez WV; Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
  • Sultana S; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research,Bangladesh Dhaka, Bangladesh.
  • Witte D; Asociación Benéfica PRISMA, Iquitos, Peru.
  • Yousafzai MT; Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
  • Awuor AO; Malawi Liverpool Wellcome Programme, Blantyre, Malawi.
  • Cunliffe NA; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
  • Jahangir Hossain M; Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
  • Paredes Olortegui M; Kenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.
  • Tapia MD; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
  • Zaman K; Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Fajara, The Gambia.
  • Means AR; Asociación Benéfica PRISMA, Iquitos, Peru.
Open Forum Infect Dis ; 11(Suppl 1): S41-S47, 2024 Mar.
Article de En | MEDLINE | ID: mdl-38532961
ABSTRACT

Background:

Comparative costs of public health interventions provide valuable data for decision making. However, the availability of comprehensive and context-specific costs is often limited. The Enterics for Global Health (EFGH) Shigella surveillance study-a facility-based diarrhea surveillance study across 7 countries-aims to generate evidence on health system and household costs associated with medically attended Shigella diarrhea in children.

Methods:

EFGH working groups comprising representatives from each country (Bangladesh, Kenya, Malawi, Mali, Pakistan, Peru, and The Gambia) developed the study methods. Over a 24-month surveillance period, facility-based surveys will collect data on resource use for the medical treatment of an estimated 9800 children aged 6-35 months with diarrhea. Through these surveys, we will describe and quantify medical resources used in the treatment of diarrhea (eg, medication, supplies, and provider salaries), nonmedical resources (eg, travel costs to the facility), and the amount of caregiver time lost from work to care for their sick child. To assign costs to each identified resource, we will use a combination of caregiver interviews, national medical price lists, and databases from the World Health Organization and the International Labor Organization. Our primary outcome will be the estimated cost per inpatient and outpatient episode of medically attended Shigella diarrhea treatment across countries, levels of care, and illness severity. We will conduct sensitivity and scenario analysis to determine how unit costs vary across scenarios.

Conclusions:

Results from this study will contribute to the existing body of literature on diarrhea costing and inform future policy decisions related to investments in preventive strategies for Shigella.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Open Forum Infect Dis Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Open Forum Infect Dis Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique